Bacterial Diagnostics in Aquaculture Market

Bacterial Diagnostics in Aquaculture Market Outlook 2032

The global bacterial diagnostics in aquaculture market size was USD 4.0 Billion in 2023 and is projected to reach USD 7.41 Billion by 2032, expanding at a CAGR of 7.1% during 2024–2032. The market growth is attributed to the increasing demand for advanced bacterial diagnostics solutions driven by rising disease prevalence and strict regulatory standards in aquaculture across the globe.

Increasing concerns about the health and sustainability of aquaculture practices have led to a growing demand for advanced bacterial diagnostics in the aquaculture industry. With the rising global population and the need for sustainable protein sources, aquaculture has become a crucial industry. The latest trend in bacterial diagnostics in aquaculture involves the development of rapid and accurate testing methods to detect and identify bacterial pathogens that affect fish and shellfish health. These advancements are driven by the growing awareness of disease outbreaks in aquaculture farms and the need to mitigate their impact on production and profitability.

Regulatory bodies and government agencies play a significant role in shaping the landscape of bacterial diagnostics in aquaculture. For example, the Europe Union (EU) has stringent regulations under EC Regulation No. 854/2004 for bacterial diagnostics in aquaculture, ensuring the safety and quality of seafood. Government regulations mandate the implementation of strict testing protocols to ensure the safety and quality of aquaculture products.

These regulations drive the adoption of innovative diagnostic technologies and encourage investment in research and development for new diagnostic solutions. Furthermore, regulatory bodies collaborate with industry stakeholders to establish standards and guidelines for bacterial diagnostics, fostering a transparent and reliable aquaculture market. For instance,

• In March 2021, Neogen announced a collaboration with the Central Veterinary Research Laboratory (CVRL) in Bahrain to develop and distribute diagnostic testing solutions for aquaculture pathogens, including bacteria. This partnership aimed to enhance the ability to diagnose and manage bacterial diseases in aquaculture settings, contributing to improved health and productivity in the industry.

Increasing adoption of sustainable aquaculture practices and the growing demand for safe and high-quality seafood products. This presents an opportunity for companies specializing in bacterial diagnostics to innovate and develop cost-effective, user-friendly, and efficient testing solutions tailored to the aquaculture industry's specific needs.

Get Free Sample Report

Impact of Artificial Intelligence (AI) in the Bacterial Diagnostics in Aquaculture market

Artificial Intelligence (AI) is revolutionizing bacterial diagnostics in aquaculture by enhancing efficiency and accuracy. AI systems analyze vast amounts of data from aquaculture operations, water quality parameters, and bacterial samples, through advanced algorithms and machine learning techniques. This analysis enables swift identification of bacterial pathogens, aiding aquaculture professionals in early detection and proactive management of diseases.

AI-powered diagnostic tools streamline the testing process and reduce manual labor, thus optimizing overall productivity and sustainability in the aquaculture industry. AI-driven bacterial diagnostics in aquaculture contribute significantly in disease prevention and biosecurity measures. AI systems predict potential disease outbreaks, recommend appropriate interventions, and optimize treatment strategies by continuously learning from data patterns.

Bacterial Diagnostics in Aquaculture Market Dynamics

Get Free Sample Report

Major Drivers

Increasing demand for sustainable aquaculture practices is driving bacterial diagnostics in the aquaculture industry. With the rising consumption of seafood globally, aquaculture producers are focusing on ensuring the health and safety of their aquatic stocks. This emphasis on sustainable practices and disease prevention is expected to fuel the demand for advanced bacterial diagnostic solutions in aquaculture facilities during the forecast period, boosting the market.

Growing prevalence of bacterial diseases in aquaculture is spurring the adoption of diagnostic technologies. Bacterial infections significantly impact aquaculture production, leading to economic losses and environmental concerns. Therefore, aquaculture operators are increasingly investing in bacterial diagnostics to detect and manage these diseases effectively, contributing to the overall growth of the market.

Advancements in technology and innovation are driving the development of new bacterial diagnostic solutions for aquaculture. Companies are leveraging molecular biology techniques, such as PCR and NGS, to create rapid and accurate diagnostic tools. These technological advancements are anticipated to revolutionize disease monitoring and management in aquaculture, driving the market.

Existing Restraints

Lack of standardized protocols and regulations for bacterial diagnostics in aquaculture is restraining the market. Inconsistent guidelines across regions lead to challenges in adopting uniform diagnostic practices, hindering the efficiency and accuracy of diagnostic tests. This lack of standardization impedes the market expansion, as aquaculture operators face difficulties in choosing reliable and validated diagnostic solutions.

Limited awareness and education about bacterial diagnostics among aquaculture stakeholders are hindering the market. Insufficient knowledge about the importance of regular diagnostic testing and disease monitoring leads to the underutilization of diagnostic tools. Inadequate training programs and educational initiatives further contribute to this restraint, impacting the adoption of advanced bacterial diagnostic technologies in aquaculture facilities.

Emerging Opportunities

­High demand for rapid and accurate diagnostic tools in aquaculture facilities is driving the development of innovative solutions. This trend is creating opportunities for companies to introduce novel diagnostic platforms that offer real-time monitoring of bacterial infections in aquatic organisms. For instance,

• In July 2023, Thermo Fisher Scientific, a key provider of laboratory equipment and services, launched bacterial diagnostics kit designed for aquaculture applications. The kit, named AquaProbe, allows aquaculture operators to quickly and accurately detect and identify bacterial pathogens in fish and shrimp farms.

Growing emphasis on preventive healthcare in aquaculture is creating new opportunities in the market. Aquaculture operators are increasingly recognizing the importance of proactive disease management strategies to prevent outbreaks and minimize economic losses. This shift toward preventive measures is driving the adoption of advanced diagnostic techniques, creating a favorable market landscape for diagnostic solution providers.

Scope of the Bacterial Diagnostics in Aquaculture Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

​​​​​
Bacterial Diagnostics in Aquaculture Market Segment Insights

Product Type Segment Analysis

Based on product type, the bacterial diagnostics in aquaculture market is trifurcated into antibiotics diagnostics, antimicrobial resistance (AMR) diagnostics, and other pathogen diagnostics. The antimicrobial resistance (AMR) diagnostics segment held a major share of the market in 2023, owing to the increasing prevalence of antibiotic resistance in aquaculture, driving the demand for advanced diagnostics to monitor and manage AMR effectively.

The other pathogen diagnostics segment is expected to expand at a significant growth rate in the coming years, due to rising awareness about the diverse pathogens affecting aquaculture, necessitating the development of specialized diagnostic solutions to ensure the health and safety of aquatic species.

Get Free Sample Report

Type of Aquatic Species Segment Analysis

On the basis of type of aquatic species, the global market is segregated into fish, shrimp, mollusks, and others. The fish segment held a large market share in 2023, attributed to the high consumption of fish globally as well as the increasing adoption of bacterial diagnostics to ensure the health and safety of fish populations in aquaculture settings.

The shrimp segment is anticipated to expand at a substantial CAGR during the projected period, due to the growing demand for shrimp as a seafood delicacy as well as the rising awareness about the importance of bacterial diagnostics in shrimp farming to prevent diseases and ensure product quality.

Type of Bacterial Pathogen Segment Analysis

Based on type of bacterial pathogen, the bacterial diagnostics in aquaculture market are segmented into vibrio species, Aeromonas species, pseudomonas species, and others. The vibrio species segment led the market in terms of revenue in 2023, owing to the widespread prevalence of vibrio species in aquatic environments and the increasing concern about their impact on aquaculture production. Additionally, water quality management and disease prevention strategies have driven the demand for diagnostics targeting vibrio species.

The Aeromonas species segment is projected to register a robust growth rate during the assessment years, due to the rising awareness of Aeromonas infections in aquaculture as well as the need for effective diagnostics to control outbreaks and ensure the health of aquatic species. Advances in molecular diagnostic technologies targeting Aeromonas species are contributing to the growth of the segment.

Get Free Sample Report

Technology Segment Analysis

On the basis of technology, the market is divided into polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and next-generation sequencing (NGS). The polymerase chain reaction (PCR) segment generated a major revenue share of the market in 2023, attributed to its high accuracy, sensitivity, and specificity in detecting bacterial pathogens in aquaculture settings. PCR-based diagnostics are widely adopted, due to their rapid results and ability to detect a wide range of bacterial species.

The next-generation sequencing (NGS) segment is expected to register a high share of the market revenue during the projection period, due to advancements in sequencing technologies and their ability to provide comprehensive genetic information about bacterial pathogens. NGS allows for high-throughput analysis, multiplexing capabilities, and detection of antimicrobial resistance genes, making it a preferred choice for advanced bacterial diagnostics in aquaculture.

Application Segment Analysis

Based on application, the bacterial diagnostics in aquaculture market is segmented into disease diagnosis, water quality monitoring, food safety testing, and others. The disease diagnosis segment led the market in terms of revenue in 2023, owing to the increasing prevalence of bacterial diseases in aquaculture species. Moreover, the rising demand for disease prevention, early detection, and efficient management strategies drove the growth of this segment. For instance,

• In November 2021, Bio-Rad introduced the iQ-Check Aspergillus Real-Time PCR Kit. This kit is designed for the rapid detection and quantification of Aspergillus species, providing enhanced diagnostic capabilities for aquaculture disease management.

The food safety testing segment is projected to register a robust growth rate during the assessment years, due to growing concerns regarding foodborne pathogens and contaminants in aquaculture products. Stringent regulations and consumer awareness about food safety are propelling the demand for bacterial diagnostics to ensure the quality and safety of aquaculture products. For instance,

• In January 2022, Neogen introduced the Reveal Q+ MAX for Aflatoxin M1 in milk showcasing its ongoing product development efforts in food safety diagnostics. Its diverse portfolio includes diagnostic solutions applicable to various industries.

End-user Segment Analysis

On the basis of end user, the market is divided into aquaculture farms, diagnostic laboratories, and research institutes & universities. The aquaculture farms segment generated a major revenue share of the market in 2023, attributed to the increasing adoption of bacterial diagnostics for disease prevention and management in aquaculture operations. Aquaculture farms are increasingly investing in advanced diagnostic solutions to ensure the health and productivity of their aquatic species, thus driving the demand for bacterial diagnostics.

The diagnostic laboratories segment is expected to lead the market in terms of revenue during the projection period, due to the rising demand for specialized testing services and accurate diagnostic results. Diagnostic laboratories play a crucial role in providing comprehensive bacterial diagnostics services to aquaculture farms and other end users, contributing to the growth of this segment.

Regional Outlook

In terms of region, the global bacterial diagnostics in aquaculture market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. Asia Pacific held a major market share in 2023, due to the dominant position in the aquaculture industry. High aquaculture production and increasing adoption of advanced diagnostic technologies by aquaculture operators in countries such as China, India, and Southeast Asia are fueling the market.

The market in North America is projected to grow at a significant pace in the forecast period, owing to the rising demand for sustainable aquaculture practices, stringent regulations on aquaculture product quality & safety, and investments in research & development of innovative bacterial diagnostics technologies by key market players in the region. For instance,

• In September 2022, the Food and Drug Administration (FDA) in the US issued updated guidelines regarding bacterial testing and monitoring protocols in aquaculture facilities. These guidelines aim to ensure the safety and quality of aquaculture products by recommending regular bacterial diagnostics and stringent monitoring of bacterial contamination levels in aquaculture water and products.
  

  Get Free Sample Report
  

Segments

The bacterial diagnostics in the aquaculture market have been segmented on the basis of

Product Type

• Antibiotics Diagnostics
• Antimicrobial Resistance (AMR) Diagnostics
• Other Pathogen Diagnostics

 Type of Aquatic Species

• Fish
• Shrimp
• Mollusks
• Others

 Type of Bacterial Pathogen

• Vibrio Species
• Aeromonas Species
• Pseudomonas Species
• Others

Technology

• Polymerase Chain Reaction (PCR)
• Enzyme-linked Immunosorbent Assay (ELISA)
• Next-Generation Sequencing (NGS)

 Application

• Disease Diagnosis
• Water Quality Monitoring
• Food Safety Testing
• Others

End User

• Aquaculture Farms
• Diagnostic Laboratories
• Research Institutes & Universities

Region

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• Eurofins Scientific
• IDvet
• Merck KGaA (EMD Millipore)
• Neogen Corporation
• QIAGEN
• Thermo Fisher Scientific Inc.
• Zoetis Inc.

Competitive Landscape

Key players competing in the global bacterial diagnostics in aquaculture market are Bio-Rad Laboratories, Inc.; Charles River Laboratories International, Inc.; Danaher Corporation (Beckman Coulter, Inc.); Eurofins Scientific; IDvet; Merck KGaA (EMD Millipore); Neogen Corporation; QIAGEN; Thermo Fisher Scientific Inc.; and Zoetis Inc.

• In January 2022, Merck KGaA announced the acquisition of AmpTec, a specialist in mRNA technology. This acquisition bolstered its capabilities in nucleic acid-based technologies, which have applications in bacterial diagnostics.

• In February 2021, Thermo Fisher announced the acquisition of Mesa Biotech, a point-of-care molecular diagnostic company. This acquisition expanded the company's capabilities in providing rapid molecular testing solutions.